Picture of Active Biotech AB publ logo

ACTI Active Biotech AB publ News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Active Biotech's Patent For Laquinimod In Eye Disorders To Be Granted In US

Nov 13 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * PATENT FOR LAQUINIMOD IN EYE DISORDERS WILL BE GRANTED IN
THE US
    * PATENT PROVIDES PROTECTION AND MARKET EXCLUSIVITY UNTIL
2040

Source text:  ID:nMFN9BkNvz 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Active Biotech AB publ

See all news